Sugi Predict

Sugi Predict / Compounds / SCHEMBL589281

SCHEMBL589281

SCHEMBL589281

Cc1cc(OCc2ccccc2)c(Br)cc1C1OCCO1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 2/20 0.50
▸ HTR2A P28223 1/20 0.50
▸ CCR5 P51681 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ PTPN1 P18031 2/20 0.39
▸ SLC6A4 P31645 2/20 0.38
▸ HTR2B P41595 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ STAT3 P40763 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ FFAR4 Q5NUL3 1/20 0.37
▸ BRD4 O60885 1/20 0.37
▸ KDM1A O60341 2/20 0.37
▸ HTR1A P08908 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31056266 0.91 HTR2C (0.46) HTR2CHTR2ACCR5MAPTMAPK1
SCHEMBL23700129 0.85 HTR2C (0.48) HTR2CHTR2ACCR5MAPTMAPK1
SCHEMBL23700093 0.85 HTR2C (0.47) HTR2CHTR2ACCR5SMN1; SMN2RAB9A
SCHEMBL27756953 0.82 HTR2C (0.46) HTR2CHTR2ACCR5SMN1; SMN2RAB9A
SCHEMBL31056681 0.82 HTR2C (0.44) HTR2CHTR2ACCR5MAPTMAPK1
SCHEMBL31056082 0.81 KDM1A (0.45) HTR2CHTR2ACCR5SMN1; SMN2RAB9A
SCHEMBL31056825 0.78 MCL1 (0.47) MAPTTDP1L3MBTL1SMN1; SMN2FFAR4
SCHEMBL31056166 0.78 HTR2C (0.41) HTR2CHTR2ACCR5MAPTL3MBTL1
SCHEMBL12702768 0.77 RAB9A (0.48) HTR2CHTR2ACCR5SMN1; SMN2RAB9A
SCHEMBL8408319 0.77 SLC6A4 (0.52) HTR2CCCR5SMN1; SMN2RAB9APTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238170-A1 5,5-Difluoro- and 5-Fluoro-5-Methyl-C-Glycoside Derivatives Useful As Dual SGLT1 / SGLT2 Modulators JANSSEN PHARMACEUTICA NV (BE) 2021-08-05 — — US disclosed
US-10815210-B2 Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators JANSSEN PHARMACEUTICA NV (BE) 2020-10-27 — — US disclosed
WO-2019215633-A1 5,5-DIFLUORO- AND 5-FLUORO-5-METHYL-C-GLYCOSIDE DERIVATIVES USEFUL AS DUAL SGLT1 / SGLT2 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-11-14 — — WO disclosed
WO-2018089449-A1 BENZOCYCLOBUTANE DERIVATIVES USEFUL AS DUAL SGLT1/SGLT2 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-05-17 — — WO disclosed
EP-2076503-B1 C-PHENYL GLYCITOL COMPOUND FOR THE TREATMENT OF DIABETES TAISHO PHARMACEUTICAL CO LTD (JP) 2013-07-17 — — EP disclosed
EP-2036901-B1 C-PHENYL 1-THIOGLUCITOL COMPOUND TAISHO PHARMACEUTICAL CO LTD (JP) 2013-05-01 — — EP disclosed
US-8115017-B2 C-phenyl 1-thioglucitol compound TAISHO PHARMACEUTICAL CO., LTD (JP) 2012-02-14 — — US disclosed
US-8115017-B2 C-phenyl 1-thioglucitol compound TAISHO PHARMACEUTICAL CO., LTD (JP) 2012-02-14 — — US disclosed
US-7973012-B2 C-phenyl glycitol compound TAISHO PHARMACEUTICAL CO., LTD (JP) 2011-07-05 — — US disclosed
US-20100069460-A1 1-PHENYL 1-THIO-D-GLUCITOL DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2010-03-18 — — US disclosed
US-20100069460-A1 1-PHENYL 1-THIO-D-GLUCITOL DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2010-03-18 — — US disclosed
US-20100022460-A1 C-PHENYL GLYCITOL COMPOUND TAISHO PHARMACEUTICAL CO., LTD. (JP) 2010-01-28 — — US disclosed
US-20100004465-A1 C-PHENYL 1-THIOGLUCITOL COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2010-01-07 — — US disclosed
US-20100004465-A1 C-PHENYL 1-THIOGLUCITOL COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2010-01-07 — — US disclosed
EP-2103607-A1 1-PHENYL 1-THIO-D-GLUCITOL DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2009-09-23 — — EP disclosed
EP-2076503-A2 C-PHENYL GLYCITOL COMPOUND FOR THE TREATMENT OF DIABETES TAISHO PHARMACEUTICAL CO., LTD (JP) 2009-07-08 — — EP disclosed
EP-2036901-A1 C-PHENYL 1-THIOGLUCITOL COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2009-03-18 — — EP disclosed
WO-2007136116-A2 C-PHENYL GLYCITOL COMPOUND FOR THE TREATMENT OF DIABETES TAISHO PHARMACEUTICAL CO., LTD. (JP) 2007-11-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022460-A1 C-PHENYL GLYCITOL COMPOUND SLC5A1, SLC5A2, SLC2A1 HTR2C 1704/4885HTR2A 2993/4885CCR5 1085/4885
US-10815210-B2 Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators SLC5A2, SLC5A1, SLC2A2 HTR2C 879/4885HTR2A 862/4885CCR5 1266/4885
US-20100004465-A1 C-PHENYL 1-THIOGLUCITOL COMPOUND SLC5A1, SLC5A2, SLC2A1 HTR2C 2471/4885HTR2A 2853/4885CCR5 1739/4885
US-20210238170-A1 5,5-Difluoro- and 5-Fluoro-5-Methyl-C-Glycoside Derivatives Useful As Dual SGLT1 / SGLT2 Modulators SLC5A2, SLC5A1, SLC2A4 HTR2C 327/4885HTR2A 496/4885CCR5 1675/4885
US-20100069460-A1 1-PHENYL 1-THIO-D-GLUCITOL DERIVATIVE SLC5A1, SLC5A2, SLC2A1 HTR2C 3563/4885HTR2A 4002/4885CCR5 3769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.